Glycare Acne Gel
- Manufacturer
- MD Formulation | Harmony Labs, Inc.
- Effective date
- 2011-07-05
- Label type
- HUMAN OTC DRUG LABEL
- Version
- 3
- Source
- full-release
- Hydrated at
- 2026-05-31 22:28:32
Label at a glance#
ProductGlycare Acne
Active ingredientSALICYLIC ACID
Label structure8 sections
Label contents#
Full prescribing information#
Salicylic Acid 1%
OTC - PURPOSE SECTION
Acne Tratment
OTC - KEEP OUT OF REACH OF CHILDREN SECTION
If swallowed, get medical help or contact a Poison Control Center right away.
INDICATIONS & USAGE SECTION
Clears up acne blemishes and helps prevent new acne blemishes.
WARNINGS SECTION
For external use only.
DOSAGE & ADMINISTRATION SECTION
Directions Cleanse skin thoroughly before applying medication.Cover the entire affected area with a thin layer 1 to 3 times dally. Because excessive drying of the skin may occur, start with 1 application daily, then gradually increase to 2 to 3 times daily if needed or as directed by a physician. If bothersome dryness or peeling occurs, reduce application to once a day or every other day.
INACTIVE INGREDIENT SECTION
Water (aqua), sd alcohol 40-b, glycolic acid, ammonium glycolate, hydroxypropyl melhylcellulose.
PACKAGE LABEL.PRINCIPAL DISPLAY PANEL
DailyMed RxNorm Mappings#
FDA-Initiated Inactive NDC Indexing#
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 66078-035-25 | 2019-10-29 | C162847 | 48780-1 | 960f7f55-da66-8e05-e053-dbdaa90a074a | Glycare Acne Gel |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 66078-035-25 | Glycare Acne | 1 in 1 CARTON | GEL | 1 | 3 | |
| 66078-035-25 | Glycare Acne | 54 in 1 CASE | GEL | 54 | 3 |
DailyMed Dashboard NDC Coverage#
DailyMed Socrata Ingredients#
| Ingredient | Type | UNII | SPL version | Uploaded |
|---|---|---|---|---|
| SALICYLIC ACID | ACTIVE INGREDIENT | O414PZ4LPZ | 3 | |
| SALICYLIC ACID | ACTIVE MOIETY | O414PZ4LPZ | 3 | |
| GLYCOLIC ACID | INACTIVE INGREDIENT | 0WT12SX38S | 3 | |
| HYPROMELLOSE 2208 (15000 MPA.S) | INACTIVE INGREDIENT | Z78RG6M2N2 | 3 | |
| WATER | INACTIVE INGREDIENT | 059QF0KO0R | 3 |
Products#
Every source-derived product name is available through these pages.
- Glycare Acne
- Glycolic Acid
- SALICYLIC ACID
- WATER
- HYPROMELLOSE 2208 (15000 MPA.S)
NDC Codes#
| Product NDC | Package NDC |
|---|---|
| 66078-035 | 66078-035-25 |
Ingredients#
Every source-derived ingredient row is available through these pages.
| Name | UNII | Kind |
|---|---|---|
| SALICYLIC ACID | O414PZ4LPZ | ACTIB |
| WATER | 059QF0KO0R | IACT |
| GLYCOLIC ACID | 0WT12SX38S | IACT |
| HYPROMELLOSE 2208 (15000 MPA.S) | Z78RG6M2N2 | IACT |
Source Document#
Inactive ingredient matches#
Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.
| DailyMed ingredient | IID ingredient | UNII | Dosage form / route | Potency | Maximum daily exposure | Match |
|---|---|---|---|---|---|---|
| HYPROMELLOSE 2208 (15000 MPA.S) | HYPROMELLOSE 2208 (15000 MPA.S) | Z78RG6M2N2 | TABLET / ORAL | 375 mg | ||
| HYPROMELLOSE 2208 (15000 MPA.S) | HYPROMELLOSE 2208 (15000 MPA.S) | Z78RG6M2N2 | CAPSULE, DELAYED RELEASE / ORAL | 222 mg | ||
| HYPROMELLOSE 2208 (15000 MPA.S) | HYPROMELLOSE 2208 (15000 MPA.S) | Z78RG6M2N2 | TABLET, FILM COATED, EXTENDED RELEASE / ORAL | 2640 mg | ||
| HYPROMELLOSE 2208 (15000 MPA.S) | HYPROMELLOSE 2208 (15000 MPA.S) | Z78RG6M2N2 | TABLET / BUCCAL | 17 mg | ||
| HYPROMELLOSE 2208 (15000 MPA.S) | HYPROMELLOSE 2208 (15000 MPA.S) | Z78RG6M2N2 | CAPSULE / ORAL | 80.25 mg | ||
| HYPROMELLOSE 2208 (15000 MPA.S) | HYPROMELLOSE 2208 (15000 MPA.S) | Z78RG6M2N2 | TABLET, EXTENDED RELEASE / ORAL | 4050 mg |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| 6e906461-55a1-4620-9406-c0f50cf9d221 | ea482e54-e5af-4b57-a75f-e8c1f473f965 | 2011-07-05 | Warnings | 6e906461-55a1-4620-9406-c0f50cf9d221 ea482e54-e5af-4b57-a75f-e8c1f473f965 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.

